The Pharmaceutical Journal
Vol 273 No 7311 p178
7 August 2004

This article
Reprint   Photocopy

  Acrobat Reader

News summary

P to GSL switches

Pfizer Consumer Healthcare has asked the MHRA to reclassify Calpol Infant Suspension, Calpol Sugar Free Infant Suspension and Calpol Six Plus Fastmelts from P to GSL. Bayer Plc has also applied to reclassify Germoloids HC Spray from P to GSL.

Comments to Amanda Lawrence, Room 14-152, Market Towers, 1 Nine Elms Lane, London SW8 5NQ (e-mail Amanda.Lawrence@mhra.gsi.gov.uk) by 14 and 6 September 2004, respectively.